comprehensive -WSS

comprehensive

author：hotspot 2025-09-28 19:25:18 - browse：3375

Researchers say they’ve been able to measure recovery from treatment-resistant depression through brain scans — a crucial step toward quantifying the impact of therapies on a condition whose progress is notoriously difficult to measure objectively. And that’s thanks to generative AI, they say.

In a small study published Wednesday — just 10 people with severe, treatment-resistant depression receiving deep brain stimulation therapy — researchers used the electrodes to record brain activity and later fed the scans into a homegrown artificial intelligence system that analyzed them for patterns. They found that it was possible to track patients’ recovery through changes in brain cells’ electrical activity.

Finding so-called biomarkers, or objective measurements reflecting depression, could help diagnose depression, track its progression, predict a relapse, and better tailor therapies to individual patients. But finding those metrics has been difficult, partly because depression’s biological impact isn’t well understood.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Federal weight loss drug coverage is 30 years out of date

WSS

How to protect patients from sexual assault

Illumina names Agilent executive as new CEO

Burning questions for the 2024 JPM Healthcare Conference

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

New weight loss drugs work. But how can they best be used?

leisure time

comprehensive

leisure time

Virginia high school admissions case could be legal follow

GSK Flovent asthma inhalers replaced by authorized generics

Guidelines to prevent youth baseball injuries need more muscle

Amazon on where the company's health care bets are headed next

Sports medicine is finally prioritizing gender equality

Stem cell treatment guidelines are released by FDA

Continuity nursing helped my family in our darkest PICU moments

The (many) problems with a new study criticizing cancer screening

Supreme Court strikes down use of affirmative action

Why psychiatrists like me stop taking insurance

focus

Antibiotic resistance and the global rise in human conflict

U.K. sequencing study surfaces new findings about tumor DNA

A single drug, study failures leave Anavex with nothing but cash

3 medical device trends to watch in 2024

A rare thyroid diagnosis led to unexpected, all

Covid hospitalizations on the rise, Humana says

explore

hotspot

entertainment

focus